Bmc Infectious Diseases Outbreaks of Streptococcus Pneumoniae Carriage in Day Care Cohorts in Finland – Implications for Elimination of Transmission

BackgroundDay care centre (DCC) attendees play a central role in maintaining the circulation of Streptococcus pneumoniae (pneumococcus) in the population. Exposure within families and within DCCs are the main risk factors for colonisation with pneumococcal serotypes in DCC attendees.MethodsTransmission of serotype specific carriage was analysed with a continuous time event history model, based on longitudinal data from day care attendees and their family members. Rates of acquisition, conditional on exposure, were estimated in a Bayesian framework utilising latent processes of carriage. To ensure a correct level of exposure, non-participating day care attendees and their family members were included in the analysis. Posterior predictive simulations were used to quantify transmission patterns within day care cohorts, to estimate the basic reproduction number for pneumococcal carriage in a population of day care cohorts, and to assess the critical vaccine efficacy against carriage to eliminate pneumococcal transmission.ResultsThe model, validated by posterior predictive sampling, was successful in capturing the strong temporal clustering of pneumococcal serotypes in the day care cohorts. In average 2.7 new outbreaks of pneumococcal carriage initiate in a day care cohort each month. While 39% of outbreaks were of size one, the mean outbreak size was 7.6 individuals and the mean length of an outbreak was 2.8 months. The role of families in creating and maintaining transmission was minimal, as only 10% of acquisitions in day care attendees were from family members. Considering a population of day care cohorts, a child-to-child basic reproduction number was estimated as 1.4 and the critical vaccine efficacy against acquisition of carriage as 0.3.ConclusionPneumococcal transmission occurs in serotype specific outbreaks of carriage, driven by within-day-care transmission and between-serotype competition. An amplifying effect of the day care cohorts enhances the spread of pneumococcal serotypes within the population. The effect of vaccination, in addition to reducing susceptibility to pneumococcal carriage in the vaccinated, induces a herd effect, thus creating a counter-effect to the amplifying effect of the cohort. Consequently, the critical vaccine efficacy against carriage, required for elimination of transmission, is relatively low. Use of pneumococcal conjugate vaccines is expected to induce a notable herd protection against pneumococcal disease.

[1]  F. J. Méndez,et al.  Epidemiological Study of Streptococcus pneumoniae Carriers in Healthy Primary-School Children , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[2]  A. Melegaro,et al.  Pneumococcal carriage in United Kingdom families: estimating serotype-specific transmission parameters from longitudinal data. , 2007, American journal of epidemiology.

[3]  F. Ball,et al.  Epidemics with two levels of mixing , 1997 .

[4]  A. Tanskanen,et al.  Clustering of serotypes in a longitudinal study of Streptococcus pneumoniae carriage in three day care centres , 2008, BMC infectious diseases.

[5]  F. Ball,et al.  Stochastic and deterministic models for SIS epidemics among a population partitioned into households. , 1999, Mathematical biosciences.

[6]  K. Auranen,et al.  Modelling transmission, immunity and disease of Haemophilus influenzae type b in a structured population , 2004, Epidemiology and Infection.

[7]  Niels Keiding,et al.  Statistical Models Based on Counting Processes , 1993 .

[8]  Susan S. Huang,et al.  Modeling community- and individual-level effects of child-care center attendance on pneumococcal carriage. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  S. Madhi,et al.  A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. , 2003, The New England journal of medicine.

[10]  A. Melegaro,et al.  A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting , 2005, Epidemiology and Infection.

[11]  Elja Arjas,et al.  Transmission of Pneumococcal Carriage in Families: A Latent Markov Process Model for Binary Longitudinal Data , 2000 .

[12]  E. Lewis,et al.  Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children , 2000, The Pediatric infectious disease journal.

[13]  A. Schuchat,et al.  Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity. , 2005, Vaccine.

[14]  K Dietz,et al.  The effect of household distribution on transmission and control of highly infectious diseases. , 1995, Mathematical biosciences.

[15]  Evgueni I. Kassianov,et al.  Estimation of a , 2007 .

[16]  S. Cauchemez,et al.  S. pneumoniae transmission according to inclusion in conjugate vaccines: Bayesian analysis of a longitudinal follow-up in schools , 2006, BMC infectious diseases.

[17]  A. J. Hall.  Infectious diseases of humans: R. M. Anderson & R. M. May. Oxford etc.: Oxford University Press, 1991. viii + 757 pp. Price £50. ISBN 0-19-854599-1 , 1992 .

[18]  Richard Platt,et al.  Post-PCV7 Changes in Colonizing Pneumococcal Serotypes in 16 Massachusetts Communities, 2001 and 2004 , 2004, Pediatrics.

[19]  P. Torzillo,et al.  Changing epidemiology of invasive pneumococcal disease in central Australia prior to conjugate vaccine: a 16-year study. , 2007, Vaccine.

[20]  R. Dagan,et al.  Marked differences in pneumococcal carriage and resistance patterns between day care centers located within a small area. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  K. Auranen,et al.  Pneumococcal carriage in children during their first two years: important role of family exposure , 2001, The Pediatric infectious disease journal.

[22]  M. Sande,et al.  Spread of Streptococcus pneumoniae in families. II. Relation of transfer of S. pneumoniae to incidence of colds and serum antibody. , 1975, The Journal of infectious diseases.

[23]  G. Mccracken,et al.  Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  Frank Ball,et al.  Optimal vaccination schemes for epidemics among a population of households, with application to variola minor in Brazil , 2006, Statistical methods in medical research.

[25]  N. Principi,et al.  Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy children. Ascanius Project Collaborative Group. , 1999, The Pediatric infectious disease journal.

[26]  K. Auranen,et al.  Estimation of vaccine efficacy against acquisition of pneumococcal carriage. , 2009, Vaccine.

[27]  A. Melegaro,et al.  Estimating the transmission parameters of pneumococcal carriage in households , 2004, Epidemiology and Infection.

[28]  K. O'Brien,et al.  Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial , 2003, The Lancet.

[29]  R. Dagan,et al.  Spread of Streptococcus pneumoniae and antibiotic-resistant S. pneumoniae from day-care center attendees to their younger siblings. , 2002, The Journal of infectious diseases.

[30]  C. Deangelis,et al.  Streptococcus pneumoniae carriage in children attending 59 Canadian child care centers. Toronto Child Care Centre Study Group. , 1999, Archives of pediatrics & adolescent medicine.

[31]  S. Obaro,et al.  Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial , 2005, The Lancet.

[32]  C. P. Farrington,et al.  Estimation of the basic reproduction number for infectious diseases from age‐stratified serological survey data , 2001 .

[33]  E. Lewis,et al.  Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. , 2000, The Pediatric infectious disease journal.

[34]  R. Dagan,et al.  Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. , 2002, The Journal of infectious diseases.